A Study to Evaluate the Immune Response to the ASP7374 and Its Safety in Healthy Adult Volunteers

Clinical trial NCT01393951 · COMPLETED

Trial details

NCT number: NCT01393951
Sponsor: UMN Pharma Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Healthy Immunogenicity of ASP7374

Start date: 2011-05-01
Primary completion: 2011-12-01
Enrollment: 165

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.